NASDAQ:XNPT - XenoPort Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$7.07 0.00 (0.00 %)
(As of 11/12/2018 04:00 PM ET)
Previous Close$7.07
Today's Range$7.07 - $7.07
52-Week Range$3.35 - $7.86
VolumeN/A
Average Volume1.22 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
XenoPort, Inc. is a biopharmaceutical company. The Company is focused on commercializing HORIZANT (gabapentin enacarbil) Extended-Release Tablets in the United States. The Company's segment is the development and commercialization of product candidates for the treatment of neurological and other disorders. Its development-stage product candidates include XP23829, XP21279 and arbaclofen placarbil. HORIZANT has been approved by the United States Food and Drug Administration for the treatment of moderate-to-severe primary restless legs syndrome in adults and for the management of postherpetic neuralgia in adults. XP23829 is a fumaric acid ester compound and a prodrug of metabolite monomethyl fumarate being developed for the treatment for patients with moderate-to-severe chronic plaque-type psoriasis and/or patients with relapsing forms of multiple sclerosis. XP21279 is a Transported Prodrug of levodopa being developed for the treatment for patients with idiopathic Parkinson's disease.

Receive XNPT News and Ratings via Email

Sign-up to receive the latest news and ratings for XNPT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry N/A
Sub-IndustryPharmaceuticals
SectorN/A
Current SymbolNASDAQ:XNPT
Previous Symbol
CUSIP98411C10
Phone+1-408-6167200

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A
Market Cap$0.00
OptionableNot Optionable

XenoPort (NASDAQ:XNPT) Frequently Asked Questions

What is XenoPort's stock symbol?

XenoPort trades on the NASDAQ under the ticker symbol "XNPT."

How were XenoPort's earnings last quarter?

XenoPort, Inc. (NASDAQ:XNPT) released its quarterly earnings results on Thursday, May, 5th. The biopharmaceutical company reported ($0.23) EPS for the quarter, missing the consensus estimate of ($0.21) by $0.02. The biopharmaceutical company earned $14.12 million during the quarter, compared to analyst estimates of $14.24 million. The firm's revenue for the quarter was up 99.7% on a year-over-year basis. During the same period in the prior year, the company posted ($0.33) EPS. View XenoPort's Earnings History.

Has XenoPort been receiving favorable news coverage?

Headlines about XNPT stock have trended negative recently, InfoTrie Sentiment reports. The research group rates the sentiment of press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. XenoPort earned a news impact score of -2.6 on InfoTrie's scale. They also assigned media headlines about the biopharmaceutical company a news buzz of 7.0 out of 10, indicating that recent press coverage is likely to have an effect on the company's share price in the near future.

How do I buy shares of XenoPort?

Shares of XNPT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is XenoPort's stock price today?

One share of XNPT stock can currently be purchased for approximately $7.07.

What is XenoPort's official website?

The official website for XenoPort is http://www.xenoport.com/.

How can I contact XenoPort?

XenoPort's mailing address is 2000 Seaport Blvd Ste 300, REDWOOD CITY, CA 94063-5584, United States. The biopharmaceutical company can be reached via phone at +1-408-6167200.


MarketBeat Community Rating for XenoPort (NASDAQ XNPT)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  131 (Vote Outperform)
Underperform Votes:  129 (Vote Underperform)
Total Votes:  260
MarketBeat's community ratings are surveys of what our community members think about XenoPort and other stocks. Vote "Outperform" if you believe XNPT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe XNPT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/12/2018 by MarketBeat.com Staff

Featured Article: Technical Analysis

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel